Washington, District of Columbia-based Xylem Inc. (XYL) designs, manufactures, and services engineered products and solutions for utility, industrial, and residential and commercial building services settings worldwide. The company has a market cap of $21.8 billion and operates through the Water Infrastructure, Applied Water, Measurement and Control Solutions and Water Solutions and Services segments.
XYL stock has lagged behind the broader market over the past year, declining 32.1% compared to the S&P 500 Index’s ($SPX) 10.7% surge. In 2026, the stock has fallen nearly 30.1%, also underperforming the SPX’s 7% rise.
Its industry benchmark, the State Street Industrials Select Sector SPDR ETF (XLI), has risen 9.9% over the past year, outperforming the stock. In 2026, XLI has grown 6.2% and has also outpaced the stock.
On Oct. 27, XYL stock tanked nearly 14.2% after releasing disappointing Q3 2026 earnings. The company’s revenue fell 3% from the prior year’s quarter to $2.2 billion, missing the Street’s estimates. The same was true for its adjusted EPS, which came in at $1.44, also below consensus estimates. Management cited project timing and cautious customer spending as the main reasons behind the company’s performance. Additionally, XYL lowered full-year adjusted earnings guidance to $5.40 to $5.45 per share, down from the previous range of $5.55 to $5.70 per share, and expects full-year revenue of $8.95 billion, also below previous estimates.
For the current year, which ends in December, analysts expect XYL’s EPS to rise 7.3% to $5.45 on a diluted basis. The company has met or surpassed the consensus estimate in three of the last four quarters, while missing on one occasion.
Among the 20 analysts covering XYL stock, the consensus is a “Moderate Buy.” That’s based on nine “Strong Buy” ratings, one “Moderate Buy,” eight “Holds,” and two “Strong Sells.”
The configuration has turned bearish over the past months, with the stock now having nine “Strong Buy” ratings, down from 12 recorded three months ago, and two “Strong Sell” ratings added this month as well.
On Oct. 29, UBS analyst Joshua Spector maintained a “Hold” rating for XYL stock and lowered its price target from $112 to $99.
XYL’s mean price target of $117.60 offers a 23.5% upside compared to the current market price. Its Street-high target of $150 implies a 57.6% upside from current levels.